PharmaSens today announced the publication of data from the first clinical study evaluating its all-in-one insulin patch pump offering. The all-in-one pump pairs the Niaa Essential insulin patch pump with the SynerG continuous glucose monitor (CGM) sensor developed by Pacific Diabetes Technologies. It features the sensor within the Niia device’s insulin infusion cannula. Existing patch […]
SiBionics
The biggest diabetes tech news out of ATTD 2026
Diabetes technology innovators gathered in Barcelona last week for the 19th annual Advanced Technologies and Treatments for Diabetes Conference (ATTD 2026). At ATTD 2026, a range of companies shared the latest updates, including product launches, new clinical data, enhancements to existing offerings and more. Topics included automated insulin delivery, continuous glucose monitors (CGMs), and breakthroughs […]
SiBionics highlights benefits of AI in CGM tech
SiBionics shared new findings about the use of AI in continuous glucose monitor (CGM) technologies. The China-based company shared new perspectives on AI at the 19th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Barcelona. It outlined how AI can extend the value of CGM technology beyond just monitoring. SiBionics develops the […]
The top diabetes tech stories of 2025
As the year comes to a close, it’s time to look back at the numerous innovations across the diabetes technology industry in 2025. Once again, continuous glucose monitors (CGMs) and automated insulin delivery systems took most of the headlines, as the leaders in the space keep building on their platforms while challengers continue to enter […]
SiBionics reports strong CGM, ketone monitoring data
SiBionics announced the presentation of new data supporting its continuous glucose monitoring (CGM) and ketone monitoring (CKM) devices. The China-based company shared findings for its integrated CGM and CKM diabetes management solution as well. It showcased the technology at the 61st Annual Meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria. […]
The biggest diabetes tech stories out of ADA 2025
The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association’s 85th Scientific Sessions. At last year’s edition in Orlando, type 2 diabetes dominated the conversation. This time around, type 2 remained a hot topic, alongside new players in the continuous glucose monitor (CGM) and automated insulin delivery market, […]
PharmaSens, SiBionics innovatively combine tech in all-in-one insulin patch pump
While many existing systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have something different to offer. Current automated insulin delivery platforms — like those offered by Insulet, Tandem Diabetes Care, Medtronic, Beta Bionics and Sequel Med Tech — link separate devices. The pump itself is either tubeless and placed […]
PharmaSens, SiBionics collab on all-in-one insulin patch pump
PharmaSens today announced a strategic partnership with SiBionics to jointly develop an all-in-one insulin patch pump. Switzerland-based PharmaSens develops the Niia Essential insulin patch pump system. The basal-bolus patch pump combines the ease of an insulin pen with the advantages of a sophisticated pump. The company submitted the pump to the FDA at the end […]
SiBionics unveils ‘world’s thinnest’ CGM, earns CE mark
SiBionics announced today that it unveiled its GS3 continuous glucose monitor (CGM), which now has CE mark approval. The company unveiled the device — which it touts as the world’s thinnest CGM — at last week’s 18th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) in Amsterdam. GS3 features an ultra-compact design and […]
Report: Court says SiBio can’t sell CGM in some European countries amid Abbott IP battle
JUVE-Patent reports that The Hague recently handed down two new decisions in a CGM patent battle between Abbott and SiBio. One case saw an Abbott patent infringement application shot down, while the other granted the U.S. medtech giant’s claim. The granted one could mean SiBio can’t distribute its CGMs in Germany, France, the Netherlands and […]
